Podcasts about Accreditation

In the premiere episode of our Coaching as a Leader podcast series, host Simone Sweeney talks to coach, supervisor and author Jen Kidby, and AC Head of Corporate Membership and Accreditation, Victoria Leith, to discuss the important topic of leader as coach and the launch of the AC's new book: Coaching as a Leader. Together, they share the inspiration behind the book and explore why coaching skills are now essential for leaders navigating today's complex, people-centred workplaces. Designed to set the stage for the series, this conversation offers a compelling introduction to the evolving role of leadership in driving culture, engagement, and performance through coaching. Jen and Victoria delve into the core themes of Coaching as a Leader, including the shift from directive, top-down management to a more collaborative, coaching-led leadership style. They highlight how key coaching competencies—such as emotional intelligence, active listening, and self-awareness—are crucial for fostering trust, clarity, and resilience within teams. The episode also offers practical guidance for leaders looking to integrate a coaching mindset into their everyday practice. Jen and Victoria emphasize the importance of aligning these skills with organizational values and strategy to create lasting impact, and the growing trend of coaching as an essential component of organizational culture post-pandemic. An inspiring conversation for leaders of any level, as well as the coaches supporting them in our ever-changing world.  You will learn:   ·       Coaching-oriented leadership fosters stronger, more supportive organizational cultures. ·       Core coaching skills—like self-awareness, active listening, and emotional intelligence—are vital for effective modern leadership. ·       Aligning coaching practices with organizational purpose enhances both individual and business performance.   “They're realizing that coaching is becoming a must, with people and strategies. Companies that are focusing on coaching cultures see a higher engagement, for various different things like innovation and retention.”   Don't forget to subscribe, rate, and leave us a review! Your feedback helps us bring you more valuable content.   For the episode resources and guest bio, please visit:  https://www.associationforcoaching.com/page/dl-hub_podcast-channel-coaching-as-a-leader-coaching-skills-leadership-book

In this episode, Dr. Shawn Griffin, CEO of URAC, joins Laura Dyrda to discuss emerging trends in healthcare, particularly the transformative role of artificial intelligence. He shares insights into URAC's upcoming AI accreditation program, the importance of setting quality standards beyond regulation, and his leadership philosophy for navigating change in a rapidly evolving industry.

“A lot of other disease sites, they have some targeted therapies, they have some immunotherapies [IO]. In lung cancer, we have it all. We have chemo. We have IO. We have targeted therapies. We have bispecific T-cell engagers. We have orals, IVs. I think it's just so important now that, particularly for lung cancer, you have to be well versed on all of these,” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer treatment. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 16, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer treatments. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episode: Episode 359: Lung Cancer Screening, Early Detection, and Disparities ONS Voice articles: Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Oncology Drug Reference Sheet: Amivantamab-Vmjw Oncology Drug Reference Sheet: Cisplatin Oncology Drug Reference Sheet: Lazertinib Oncology Drug Reference Sheet: Nivolumab and Hyaluronidase-Nvhy Oncology Drug Reference Sheet: Fam-Trastuzumab Deruxtecan-Nxki Optimize Your Testing Strategy and Improve Patient Outcomes With NeoGenomics' Neo Comprehensive™–Solid Tumor Assay Clinical Journal of Oncology Nursing article: Oncogenic-Directed Therapy for Advanced Non-Small Cell Lung Cancer: Implications for the Advanced Practice Nurse ONS Biomarker Database ONS video: What is the role of the KRAS biomarker in NSCLC? Biomarker Testing in Non-Small Cell Lung Cancer Discussion Tool ONS Huddle Cards: Checkpoint inhibitors External beam radiation Monoclonal antibodies Proton therapy To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Unfortunately, because lung cancer is pretty aggressive, we'll see lung cancer mostly in stage IV. So about 50%–55% of all cases are not caught until they are already metastatic, or stage IV. And then about another 25%–30% of cases are caught in stage III, which means they're locally advanced and often not resectable, but we do still treat that with curative intent with concurrent chemoradiation. And then 10%–20% of cases are found in the early stage, and that's stage I and II, where we can do surgical approaches.” TS 2:53 “The majority of radiation that you're going to see is for patients with stage III disease that's inoperable. At my institution, a lot of stage III is inoperable. Now, neoadjuvant immunotherapy has changed that a little bit. But if you have several big, bulky, mediastinal lymph nodes that makes you stage III, surgery is probably not going to be a great option. So we give curative-intent chemoradiation to these patients.” TS 10:51 “Oligoprogression would mean they have metastases but only to one site. And sometimes we will be aggressive with that. Particularly, there's good data, if the only site of progression is in the brain, we can do stereotactic radiation to the brain and then treat the chest with concurrent chemoradiation as a more definitive approach. But outside of that, the majority of stage IV lung cancer is going to be treated with systemic therapy.” TS 15:00 “It's important for nurses to know that there's a lot of different options now for treatment. Probably one of the most important things is making sure patients are aware of what their biomarker status is, what their PD-L1 expression level is, and make sure those tests have been done. … It's good that the patients understand that there's a myriad of options. And a lot of that depends on what we know about their cancer, and then that guides our treatment.” TS 31:05

What happens after a pet passes away, and how can pet professionals support owners through this difficult time? Donna Shugart-Bethune, Executive Director of the International Association of Pet Cemeteries and Crematories (IAOPCC), shares the importance of ethical pet aftercare. She discusses the industry's lack of federal regulation, the role of IAOPCC in setting standards, and why transparency and trust are essential. Donna shares insights on the evolution of pet cremation, the impact of grief, and how professional pet sitters can guide clients in making informed aftercare decisions. This conversation highlights the importance of self-regulation and education in ensuring pet owners receive compassionate, reliable services. Main Topics: The Evolution of Pet Aftercare – How cremation became the dominant choice. Self-Regulation in an Unregulated Industry – Why setting ethical standards is crucial. Transparency & Trust in Pet Cremation – How IAOPCC ensures accountability. Supporting Clients Through Pet Loss – The role of pet sitters in aftercare discussions. The Future of Pet Aftercare – Trends in cremation, memorialization, and eco-friendly options. Main Takeaway: “The biggest factor we have within our industry is trust. It's so important to know that you can trust the person taking your baby into their care.” – Donna Shugart-Bethune Losing a pet is heartbreaking, and pet owners deserve to know their beloved companion is treated with dignity and care. In our latest episode, we sit down with Donna Shugart-Bethune of IAOPCC to discuss the importance of transparency, ethical pet cremation, and how pet sitters can support clients through pet loss. Because trust matters—especially in the moments that mean the most. Listen now! #PetAftercare #PetSitterConfessional #TrustMatters About our guest: Donna Shugart-Bethune is a part of the Shugart Family operations of Pet Angel Memorial Centers in Atlanta, Georgia. The Shugart Family has been in the pet aftercare industry for more than 53 years. Pet Angel Memorial Centers operates four office locations and two pet cemeteries specializing in pet and equine cremations. Considered one of the nation's premier pet funeral homes, Pet Angel Memorial Center in Atlanta features three counseling rooms, two chapels, and the largest showroom in the nation offering more than 450 memorial products. Offering Same Day Services, Viewings and Visitations, along with superior client care, Pet Angel Memorial Centers has led the way in establishing excellence in pet aftercare. Donna, who grew up in the Shugart family business, has more than 36 years of experience in the pet aftercare industry. She has served as the Executive Director for the IAOPCC for more than 14 years. Donna played a crucial role in developing the IAOPCC's online certification programs, which are available today. She also introduced Digital Badging Certification Programs for IAOPCC Members and implemented the Accreditation Mobile App Program, providing worldwide access to Accreditation. Links: https://www.iaopc.com Check out our Starter Packs See all of our discounts! Check out ProTrainings Code: CPR-petsitterconfessional for 10% off

Parkinson's: Diagnosis and Treatment Evaluation and Credit:  https://www.surveymonkey.com/r/medchat78 Target Audience             This activity is targeted toward primary care physicians and advanced providers. Statement of Need This podcast will provide an overview of the diagnosis and management of Parkinson's disease including screening guidelines to improve early recognition. In that early symptoms of Parkinson's disease can mimic other conditions, for early recognition a review of this will be highlighted. The goal of this podcast is to provide tools for early recognition and management to maintain a patient's quality of life. According to the Parkinson's Foundation, there are approximately 90,000 people in the U.S. diagnosed with Parkinson's each year, which represents significant increase.  Objectives  Define Parkinson's disease and highlight its prevalence. Explain the signs and symptoms of Parkinson's disease, including the moto and non-motor manifestations. Outline the diagnostic criteria for Parkinson's disease, including clinical evaluations, neurological exams and applicable testing. Discuss the management of Parkinson's disease symptoms, addressing pharmacological treatments, surgical options and multidisciplinary team strategies to optimize patient care. ModeratorGregory E. Cooper, M.D., Ph.D. Neurologist Chief of Adult Neurology and Director of the Memory Center Norton Neuroscience Institute Louisville, Kentucky SpeakerJason L. Crowell, M.D. Neurologist and Movement Disorders Specialist Norton Neuroscience Institute Louisville, Kentucky  Moderator and Planner Disclosures  The moderator, Gregory E. Cooper, M.D., Ph.D, discloses relevant financial relationships with Eli Lilly and Eisai as a principal investigator. The planners of this activity do not have any relevant financial relationships with ineligible companies to disclose.   Speaker DisclosureThe speaker, Jason L. Cromwell, M.D. discloses a relevant financial relationship with the ineligible company AbbVie as a consultant and CND Life Services in research.  All relevant financial relationships have been successfully mitigated. Commercial Support There was no commercial support for this activity.    Physician Credits Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing CreditsNorton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.50 ANCC CE contact hours.  In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.  For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org. Resources for Additional Study/References  Perspectives of People At-Risk on Parkinson's Prevention Research https://pubmed.ncbi.nlm.nih.gov/38489198/ Risk of Parkinson Disease Among Adults With vs Without Posttraumatic Stress Disorder https://pubmed.ncbi.nlm.nih.gov/35925604/ Date of Original Release | May 2025; Information is current as of the time of recording.  Course Termination Date | May 2028 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.  

“The signaling and that binding of the MET and the HGF help, in a downstream way, lead to cell proliferation, cell motility, survival, angiogenesis, and also invasion—so all of those key cancer hallmarks. And because of it being on an epithelial cell, it's a really good marker because it's found in many, many different types of cancers, so it makes it what we call kind of a nice actionable mutation,” ONS member Marianne Davies, DNP, ACNP, AOCNP®, FAAN, senior oncology nurse practitioner at Yale Comprehensive Cancer Center in New Haven, CT, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the MET inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 9, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to MET inhibitors. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs ONS Voice articles: Oncology Drug Reference Sheet: Amivantamab-Vmjw Oncology Drug Reference Sheet: Cabozantinib Oncology Drug Reference Sheet: Capmatinib Oncology Drug Reference Sheet: Tepotinib Predictive and Diagnostic Biomarkers: Identifying Variants Helps Providers Tailor Cancer Surveillance Plans and Treatment Selection ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Safe Handling of Hazardous Drugs (fourth edition) Telephone Triage for Oncology Nurses (third edition) ONS courses: Safe Handling Basics ONS Biomarker Database ONS Huddle Cards: Monoclonal Antibodies Targeted Therapy ONS Oral Anticancer Medication Learning Library ONS Oral Anticancer Medication Toolkit ONS and NCODA Oral Anticancer Medication Compass Oral Chemotherapy Education Sheets IV Chemotherapy Education Sheets Drugs@FDA To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “The MET receptor was actually identified back in 1984. And it was actually identified as an oncogene in osteosarcoma. And so basically what that MET receptor does—it's a tyrosine kinase pathway, and the ligand that it attaches to is something called HGF/SF. That's hepatocyte growth factor/scatter factor. And so this MET pathway tyrosine kinase pathway is really important in tumor cell growth and migration. And it's expressed specifically on epithelial cells, so that's going to really help us in identifying how it can be a pathway for cancer treatments.” TS 1:35 “But in the particular classes, there kind of are some unique things that are with these MET inhibitors. For example, crizotinib, we found early on, causes some vision changes. Patients would report things like floaters or a little bit of blurry vision. For the capmatinib, things like elevation of amylase and lipase, fluid retention and bloating, and hypersensitivity reactions and photosensitivity.” TS 7:36 “Other things to teach for the TKI is the self-management strategies in terms of nausea management and dietary changes for the risk of peripheral edema. Having them do things like maybe doing daily weights, or at least weights every other day, and sometimes doing limb measurements so it can help us really quantify the amount of fluid retention they have. And then from a nursing perspective, meeting with these patients, is to do really good skin inspection. When people have peripheral edema, they're at risk for skin breakdown, and that can lead obviously to infection.” TS 16:06 “The biggest [misconception] is that people assume that all MET mutations are going to be equally responsive to the same targeted therapies, that all of the abnormalities are the same and react the same, and they really don't. We're really diving down and carving that pie thinner and thinner in terms of each individual MET abnormality, in terms of what drugs responds it to and what that means for patient outcomes and prognosis.” TS 25:21

FAIR News Weekly | 5/9/25

Dr. Natasha Bagdasarian, Chief Medical Executive for the state of Michigan, explains the state's Public Health Data Dashboard, which visualizes public health trends by district and helps to shape awareness of public health's role in the community; David Stone, Accreditation Analyst at ASTHO, discusses the importance of accreditation and ASTHO's guide to sustaining efforts across health departments; Dr. Scott Harris, ASTHO President and State Health Officer for Alabama, appeared on a recent Public Health on Call podcast; Dr. Nirav Shah, former ASTHO President and former Director of the Maine Center for Disease Control and Prevention, will give the commencement address at the University of Maine in Farmington; ASTHO will host an event being an effective crisis communicator Thursday, May 8th. Michigan's Public Health Data Dashboard  ASTHO: A Guide for Sustainable Public Health Accreditation Podcast: A Conversation with Alabama's State Health Officer ASTHO: Don't Panic: A Panel on How to be an Effective Crisis Communicator UMF Announces Dr. Nirav Shah as Commencement Speaker  

Let's Be Honest: Money talk isn't tacky—it's transformative.This week, Andrea's flipping the script on the financial silence that's held women back for generations. From candid salary conversations to sharing investment wins (and missteps), every truth you tell chips away at a system built on keeping women in the dark. Tune in to explore how owning your financial story can unlock not just personal freedom, but collective empowerment. It's not about becoming money-obsessed, but about making money part of your wellness journey.. . .0:00 - Episode Intro2:23  - When Financial Silence Hurts Us All3:34 -  The Curious Case of Financial Confidence5:16 - Were You Silent, or Silenced?6:54 - Internalized Money Misogyny 9:07 - Saying the Quiet Part Out Loud Benefits Everyone10:11 - Pay Transparency = Pay Equity11:05 -  Kicking Off The Hard Conversation14:51 - Community Makes Everything Better15:37 - Closing Thoughts . . . RESOURCES ⁠⁠Get info about our upcoming Mastermind cohort!⁠⁠. . .CONNECT WITH KANDULAteam@kandulacommunications.com. . .CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Summary In this episode of the Develop This Podcast, host Dennis Fraise interviews Jim Fram, a seasoned economic development professional with over 30 years of experience. They discuss Jim's leadership style, the importance of listening, adapting to different community needs, and the significance of accreditation in economic development organizations. Jim shares insights on the pitfalls young leaders face, the value of volunteering, and his transition into consulting after retirement. The conversation concludes with Jim emphasizing the importance of benchmarking and continuous learning in leadership. Consultant & Economic Development LeaderConsultant & Economic Development Leader Community Growth Strategies, LLC · Takeaways Jim Fram is a highly accomplished economic development professional. Leadership is often only evident when it is poor. Listening more than talking is crucial for effective leadership. Adapting leadership style to different communities is essential. Young leaders should avoid making sudden moves. Accreditation validates organizational practices and ethics. Personal credentials enhance professional reputation. Volunteering allows experienced leaders to give back. Consulting can be a fulfilling post-retirement career. Benchmarking with other organizations is vital for growth.

Summary In this episode of Develop This, Dennis Fraise speaks with Tom Manskey, the Director of Economic Development for the Odessa Development Corporation. They discuss the unique economic landscape of Odessa, Texas, especially its reliance on the oil and gas industry, the importance of diversifying the economy, and the emerging focus on green energy initiatives. Tom shares insights into the growth of the healthcare and education sectors, the community's quality of life, and the challenges and opportunities presented by the current economic conditions. The conversation highlights Odessa's potential for future growth and development. Takeaways Odessa is a significant player in the oil and gas industry, contributing 40% of the U.S. output. Economic diversification is crucial for Odessa's long-term sustainability. The Permian Basin has a rich history and a promising future in energy production. Green energy initiatives are gaining traction in Texas, complementing traditional energy sources. A major direct air carbon capture facility is being developed in Odessa. The healthcare and education sectors are growing rapidly in the region. Quality of life improvements are essential for attracting new residents and businesses. Workforce development is a priority to meet the needs of local employers. Odessa's community spirit and work ethic are key assets for economic development. The future of Odessa looks bright with ongoing projects and investments.

Send us a textJoin host Alex Sarlin alongside special guest co-hosts Ben Wallerstein and Anna Kimsey Edwards, Co-Founders of Whiteboard Advisors, as they break down:[00:03:00] Trump's AI Executive Order launches cross-agency education task force[00:05:00] 27 states already advancing AI education policy[00:07:00] Workforce EO targets 1M AI-related apprenticeships[00:10:00] Accreditation EO pushes competition and student outcomes[00:14:00] “Beyond Degrees” report urges non-degree pathways[00:21:00] Edtech funding hits record low in Q1 and Q2, says HolonIQ[00:23:00] ESSER cliff and political uncertainty stall school spending[00:28:00] Falling enrollment squeezes K-12 budgets nationwide[00:30:00] Duolingo adds 150 AI-generated cross-language courses[00:30:45] Google Audio Overview now available in 50 languages[00:31:00] Panorama acquires AI writing tool Class Companion, Kollegio raises seed round for AI college advising[00:32:30] Anthropic forecasts AI-only employees within a year[00:36:00] Israel announces national rollout of AI tutors in schoolsPlus, special guests:[00:36:45] Anna Iarotska, CEO & Co-founder of Robo Wunderkind, unveils the first K–5 AI Literacy Curriculum[00:50:55] Julia Dixon, Founder & CEO of ESAI, reflects on her Shark Tank debut and democratizing admissions advising[01:02:00] Tigran Sloyan, Co-Founder & CEO of CodeSignal, shares how TED Talks are becoming interactive learning journeys

Strategic affiliation in higher education offers an alternative path for institutional sustainability—one that maintains mission and autonomy while accessing shared infrastructure and support. In this episode of the Changing Higher Ed® podcast, Dr. Drumm McNaughton speaks with Dr. Matt Nehmer, President of The Colleges of Law, about his institution's affiliation with The Community Solution Education System (TCS) and what other leaders should know before pursuing similar strategies. Drawing on his experience as both a college president and former system executive, Nehmer shares how the affiliation was structured, how accreditation and compliance were handled, and what shared services have allowed The Colleges of Law to professionalize operations without sacrificing identity. This conversation is especially relevant for presidents, trustees, and institutional leaders considering affiliation models to improve long-term viability. Topics Covered: Why The Colleges of Law pursued affiliation before it became a necessity The dual-board governance structure that balances autonomy and accountability How legal safeguards protected institutional assets during transition Shared services provided through The Community Solutions system and how they're managed Accreditation coordination with WASC and the implications of a system model Academic collaboration across system institutions without curriculum loss Leadership communication and the president's role in system-level engagement Real-World Examples Discussed: Asset protection using a legacy nonprofit entity Cross-listed family law course shared with affiliated institutions Accreditation contingency planning in case of system dissolution Strategic planning coordination across multiple colleges Three Key Takeaways for Leadership: Presidents must actively educate stakeholders about how system affiliation works. Legal and governance structures matter—protect assets and clarify responsibilities. Affiliation doesn't require cultural compromise; it enables operational focus. This episode provides practical insights for institutions exploring strategic affiliation as a pathway to long-term resilience without sacrificing independence. Recommended For: Presidents, trustees, board members, general counsel, provosts, and system executives considering affiliation or system alignment models in higher education. Read the transcript: https://changinghighered.com/strategic-affiliation-in-higher-education/ #HigherEdLeadership #StrategicAffiliation #Governance #HigherEducationPodcast

Thanks to our Partners, NAPA TRACS, and Today's Class Mike Coley and George Arrants from the ASE Education Foundation address the ongoing technician shortage in the automotive industry. They highlight the importance of education, mentoring, and industry involvement in developing career-ready talent. Coley discusses how ASE certification improves retention and productivity, while Arrants emphasizes the value technicians place on a positive shop culture and proper equipment. The episode urges shop owners to actively support schools, nurture entry-level talent, and create environments that promote long-term career development. Mike Coley and George Arrants, ASE Education Foundation: https://www.aseeducationfoundation.org/ Show Notes: Watch Full Video Episode Technician Shortage Discussion (00:00:00) Always Be Recruiting (00:03:43) Hiring Challenges (00:05:07) Importance of Career Path (00:06:17) Understanding Technician Turnover (00:09:11) Evaluating Technicians (00:14:11) Engaging with Schools (00:15:27) Importance of Brand Recognition (00:16:30) Career Fair Engagement (00:18:41) Understanding Young Workers' Needs (00:22:00) Role of ASE in Education (00:23:42) Aligning Education with Industry Needs (00:26:54) Impact of Accreditation (00:29:03) Elevating Student Expectations (00:33:17) Industry Accountability (00:34:14) Success Stories in Education (00:36:24) Turnover and Technician Shortage (00:38:12) Benefits of ASE Certification (00:38:25) Thanks to our Partner, NAPA TRACS NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS on the Web at http://napatracs.com/ Thanks to our Partner, Today's Class Optimize training with Today's Class: In just 5 minutes daily, boost knowledge retention and improve team performance. Find Today's Class on the web at https://www.todaysclass.com/ Connect with the Podcast: -The Aftermarket Radio Network: https://aftermarketradionetwork.com -Follow on Facebook: https://www.facebook.com/RemarkableResultsRadioPodcast/ -Join Our Private Facebook Community: https://www.facebook.com/groups/1734687266778976 -Join Our Virtual Toastmasters Club: https://remarkableresults.biz/toastmasters -Subscribe on YouTube: https://www.youtube.com/carmcapriotto -Follow on LinkedIn:

Summary In this Develop This! episode, Dennis and Mark Perna discuss the crucial importance of uniting communities around shared goals and achieving genuine consensus. They explore the challenges of building consensus in a polarized world, the significance of understanding younger generations, and the necessity of delivering education with purpose. Mark emphasizes the need to break down silos and create a competitive advantage for communities by connecting education and employment. The conversation outlines actionable steps for transitioning from collaboration to consensus, ultimately fostering a thriving community. Takeaways A rallying point is essential for community progress. Understanding young people's perspectives is crucial for economic development. Consensus is necessary for actionable outcomes in communities. Collaboration without consensus leads to stagnation. Education must be relevant and purposeful to engage younger generations. Communities need to connect educational pipelines to workforce needs. Passion is found through resilience and grit, not just interest. Breaking down silos is key to community growth and development. Hope can be cultivated through actionable steps and understanding. Engaging young people can transform community dynamics.

Summary In this episode of the Develop This Podcast, Dennis Fraise interviews Bill Cronin, the President and CEO of the Pasco Economic Development Council. They discuss the Council's recent achievement of becoming an Accredited Economic Development Organization (AEDO). Bill shares insights into the motivations for pursuing AEDO accreditation, the rigorous application process, and the team's involvement. He emphasizes the significance of ethics training and explains the preparation required for the site visit, as well as the importance of engaging stakeholders. The conversation also highlights the recognition the organization has received from the community and offers advice for other organizations considering the AEDO process. Takeaways The AEDO accreditation is a significant achievement for economic development organizations. Accreditation provides a quality seal of approval for organizations. The application process requires thorough documentation and team collaboration. Ethics training is an essential component of the accreditation process. Engaging stakeholders is crucial during the site visit preparation. The site visit allows for a comprehensive evaluation of the organization. Receiving the AEDO designation boosts morale and recognition within the community. Feedback from stakeholders can reveal positive aspects of the organization. The accreditation process encourages continuous improvement. Organizations should not hesitate to pursue AEDO accreditation.

The Dean's List with Host Dean Bowen – Trump recently signed an Executive Order that places the removal of DEI as part of the accreditation process. Trump tackles the removal of DEI from accreditation. The Department of Education said it will push existing accreditors to focus on lowering college costs, foster innovation, and deliver a high-quality education...

Episode 58 When Michelle Taylor lost her son in a tragic house fire, she thought the nightmare couldn't get worse. She was wrong. Fueled by junk science, broken forensics, and a crime lab running on expired credibility, the prosecutors turned a grieving mother into a murder suspect. Twelve debris samples. Twelve false positives. And a justice system more interested in closing a case than finding the truth. This is the story of how bad science—and worse judgment—can burn an innocent life to the ground. Michelle Taylor stands for sentencing on May 30th. The fire didn't destroy her life. The system did. A mother's grief. A lab's lies. A system that chose conviction over truth. This is Michelle Taylor's story. This podcast is a true crime podcast about arson and criminal fires. Listener discretion is recommended.  Background music by Not Notoriously Coordinated  Get your Crime to Burn Merch! https://crimetoburn.myspreadshop.com Please follow us on Instagram, X, Facebook, TikTok and Youtube for the latest news on this case. You can email us at crimetoburn@gmail.com We welcome any constructive feedback and would greatly appreciate a 5 star rating and review.  Listen to us on our friend Taylor Ruddle's podcast, Ruddle Me This right here: https://www.ruddlemethis.com/118-april-leland-from-crime-to-burns-tiny-joys/ If you need a way to keep your canine contained, you can also support the show by purchasing a Pawious wireless dog fence using our affiliate link and use the code "crimetoburn" at checkout to receive 10% off. Pawious, because our dog Winston needed a radius, not a rap sheet.  Source List: Segura L. Smoke and Errors - The Arson Evidence Doesn't Hold Up. Florida is About to Convict her for Murder Anyway. The Intercept. March 31, 2025.  https://theintercept.com/2025/03/31/florida-michelle-taylor-arson-fire-murder-trial/ Segura L. Facing Life in Prison Based on Shoddy Evidence, A Florida Mother Makes a Deal. The Intercept. April 12, 2025. https://theintercept.com/2025/04/18/michelle-taylor-florida-arson-fire-plea-deal/ Smith S. Flawed Arson Science and the Michelle Taylor Case. Smith Forensic Blog. https://smithforensic.blogspot.com/2025/04/michelle-taylor-florida-from-our-and.html Bureau of Forensic Services. Florida Department of Law Enforcement (FDLE) Official Statements on Accreditation and Quality Control Procedures. https://www.fdle.state.fl.us/ National Institute of Justice. Arson Investigation and Evidence Handling Standards. National Institute of Justice (NIJ). https://nij.ojp.gov/ Taylor M. Plea Agreement. State of Florida v. Michelle Taylor. Case No: 21001215CFMA. Filed April 2, 2025. State of Florida. Criminal Complaint. State of Florida v. Michelle Taylor. Case No: 21001215CFMA. Filed August 9, 2021. Taylor M. Motion to Exclude Similar Fact Evidence. State of Florida v. Michelle Taylor. Case No: 21001215CFMA. Filed April 19, 2024. State of Florida. Indictment. State of Florida v. Michelle Taylor. Case No: 21001215CFMA. Filed August 9, 2021. Lentini J. A Model for Confronting Fire Investigation Errors. Fire and Arson Investigator. 2020;71(3):36-45. Available from: https://www.firearson.com/ State of Florida. Amended Notice of Similar Fact Evidence. State of Florida v. Michelle Taylor. Case No: 21001215CFMA. Filed 2024. Taylor M. Plea Agreement. State of Florida v. Michelle Taylor. Case No: 21001215CFMA. Filed April 2, 2025.  Holbrook,J. Florida's Arson Lab Loses Accreditation, Wrongful Charges a Main Concern. ABC Action News. August 16, 2016.  https://www.abcactionnews.com/news/local-news/i-team-investigates/floridas-arson-lab-loses-accreditation?utm_source=chatgpt.com Pipitone, T. Experts Question State Fire Marshal Lab. NBC Miami. September 6, 2016. https://www.nbcmiami.com/news/local/experts-question-state-fire-marshal-lab/1979453/?utm_source=chatgpt.com Bousquet, S. With State Fire Lab Stripped of National Accreditation, CFO Jeff Atwater Fights Back. Tampa Bay Times. August 17, 2016. https://www.tampabay.com/news/politics/stateroundup/with-state-fire-lab-stripped-of-national-accreditation-cfo-jeff-atwater/2289678/?utm_source=chatgpt.com Bosusquet, S. Florida's Only State-Run Fire Lab Stripped of National Accreditation. Miami Herald. August 17, 2016. https://www.miamiherald.com/news/state/florida/article95921822.html?utm_source=chatgpt.com Harvey, M. St. Johns County Woman Pleads No Contest to Manslaughter in Death of her 11-year-old Son. First Coast News. April 10, 2025. https://www.firstcoastnews.com/article/news/crime/st-johns-county-woman-pleads-no-contest-to-manslaughter-in-death-of-11-year-old-son/77-f757a62e-b153-40f1-8d5c-ccfaa0daa653?utm_source=chatgpt.com Avanier, E. St Augustine Mom Accused of Setting Fire that Killed her Child to Get Insurance Money. News 4 Jax. August 10, 2021. https://www.news4jax.com/news/local/2021/08/10/st-augustine-mom-accused-of-setting-fire-that-killed-her-child-to-get-insurance-money/?utm_source=chatgpt.com Lucas Learns. GC-MS for Beginners (Gas Chromatography Mass Spectrometry). YouTube. https://www.youtube.com/watch?v=F9NUXkyIl5A Accessed: April 2025.  Lucas Learns. How to Interpret Mass Spectrometry Graphs. YouTube. https://www.youtube.com/watch?v=b59u_BHOlnk Accessed: April 2025. Lucas Learns. Mass Spectrometry Explained. YouTube. https://www.youtube.com/watch?v=SKokuAB5CKk Accessed: April 2025. Katelyn Perrault. Viewing Fire Debris Chromatograms. YouTube. https://www.youtube.com/watch?v=ijJ6qh2VrR8 Accessed: April 2025. Lentini, J. Scientific Protocols for Fire Investigation, Third Edition. CRC Press. September 2018. 

The English Language leader's debate on April 17 ended with the abrupt cancellation of standard post-debate scrum. At the centre of the incident was the accreditation of right-wing Rebel News and tensions between them and journalists at the event. We talk with the Tyee's Jen St. Denis about what happened that evening in Montreal.

“Everyone's brain is extremely heterogenic, so it's different. You can put five of us in a room; we can all have the same diagnosis of a [glioblastoma multiforme], but all of ours can be different. They're highly aggressive biologically. It's a small area in a hard shell. So trying to get through the blood–brain barrier is different. There's a lot of areas of hypoxia in the brain. There's a lot of pressure there. The microbiology is very different—it's a cold environment versus a hot environment—and then the pathways are just different,” Lori Cappello, MSN, APN-C, CCRP, research advanced practice nurse at the John Theurer Cancer Center of Hackensack Meridian Health in New Jersey, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about brain malignancies and caring for patients with them. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by April 25, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to brain malignancies and their diagnosis and treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 235: Self-Advocacy Skills for Patients Episode 166: Cognitive Behavioral Interventions Help Patients With a Spectrum of Cancer Symptoms ONS Voice articles: Glioblastoma Diagnosis, Treatment, Side Effect Management, and Survivorship Recommendations Blocking Fatty Acid Storage May Induce Glioblastoma Apoptosis Brain Tumor Navigator Role Bridges the Intersection of Cancer and Neuroscience Researchers Tie More Cancers, Mortality to NF1 Disorders Larotrectinib and Other Tumor-Agnostic Targeted Therapies Are Leading Cancer Care Into the Next Frontier McCain Announcement Sheds Light on Nurses' Role in Advance Care Planning ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) Clinical Journal of Oncology Nursing articles: Implementing a Standardized Educational Tool for Patients With Brain Tumors Undergoing Concurrent Temozolomide and Radiation Therapy Exercise Intervention: A Pilot Study to Assess the Feasibility and Impact on Cancer-Related Fatigue and Quality of Life Among Patients With High-Grade Glioma Society for Neuro-Oncology Musella Foundation End Brain Cancer Initiative Brain Tumor Network American Brain Tumor Association Glioblastoma Research Organization Brain Tumor Funders' Collaborative Optune Gio® website Nurse.org article: Mysterious Brain Tumor Cluster Grows: Another Nurse Diagnosed at Newton-Wellesley Lori Cappello's contact information: lori.cappello@hmhn.org To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “A glioblastoma actually is the most predominant brain tumor that we do see. It is the most diagnosed of the brain tumors. And then I would say that an anaplastic astrocytoma is probably the second diagnosed. Historically a GBM, they used to say was probably an elderly patient for these. But we are definitely seeing it diagnosed at a much younger age now, definitely much more prevalent for people under 60.” TS 3:17 “Nine times out of ten, either a patient out of nowhere has a seizure, or they present with what they think are stroke-like symptoms. They noticed that they were slurring, or they were becoming more forgetful, or a family member noticed it and said, ‘Hey, what is going on with you?' But usually they present to the [emergency department], and a [computed tomography] scan is always done first. And lo and behold, something is seen.” TS 4:50 “The only other U.S. Food and Drug Administration-approved treatment that has come along in the last 20 years is a device called Optune Gio, which is an alternating electric field that stops cell division at the mitosis stage.” TS 7:45 “They lose so much of their independence, especially if they don't have a caregiver or help. That is huge. Medication management at home, to making sure that they're taking the medication properly, that they are actually taking their medication. Transportation is another huge problem. Getting to and from appointments is a challenge. Those are big issues—real, day-to-day, simple issues that people don't think about.” TS 17:11 “I think that having a brain tumor is very unique in the fact that you really need a dedicated neuro-oncologist. And depending on where you live, there are not a lot in the area. I actually had a patient that was moving out west, and the closest dedicated neuro-oncologist was four hours from them. … if you're not seeing dedicated neuro oncologists, you might not be getting the best treatment for yourself. So I think that having the resources and helping patients find the best care or the best brain tumor society—and there's a bunch of really good brain tumor groups to help patients find the best resources out there. I think that's really, really important for patients to know or for families to know.” TS 19:17 “So trying to help patients, there are always going to be challenges, and there are always going to be ups and downs. But finding that one person that they can go to, that they trust, that they have a great relationship with, whether at the doctor's office or whatever, and being available to them makes such a difference in their journey. I think that that is the most important for anybody in the journey.” TS 22:08 “With brain, there are going to be expectations. They are going to lose functionality at some point—and preparing them for that thing or preparing them for things that can help themselves. Like sometimes I say, ‘Go to the dollar store, get coloring books,' if they have weakness in one hand. Little tricks of the trade that can help them. About treatment options, going through the side effects, preparing them for whatever they can be prepared for.” TS 22:39 “It is not one of the better cancers to have, but it doesn't immediately mean it's a death sentence, and we shouldn't treat them like they're dying. We shouldn't take away their ability to live just because they were diagnosed with it. We shouldn't take away hope.” TS 25:35 “I think there's not enough discussed about [brain malignancies] and the lack of resources for this. These patients need a lot more resources and are available. There's just not enough available for it.” TS 26:59

In this episode of Confessions of a Higher Ed CMO, Jaime Hunt sits down with leadership coach, author, and longtime friend Melissa Farmer Richards to unpack her new book, The 30-60-90 Day Handbook. The conversation dives deep into how new and seasoned leaders alike can thrive in higher ed by mastering the fundamentals of trust, credibility, and commitment—while navigating modern leadership challenges like burnout, crises, and emerging AI tools. Whether you're stepping into a VP role or eyeing leadership from your current position, this episode offers actionable strategies to lead with authenticity and resilience.The 30-60-90-Day Handbook: Checklists for Communications and Marketing Leaders in Higher EducationGuest Name: Melissa Richards, Founder and Principal, iMarketingMixGuest Socials: LinkedIn: http://www.linkedin.com/in/melissafarmerrichardsInstagram: https://www.instagram.com/imarketingmix/Bluesky Social: https://bsky.app/profile/melissarichards.bsky.socialGuest Bio: Principal and founder of iMarketingMix LLC, Melissa Farmer Richards, MPA, APR is an author, teacher, consultant, facilitator, and leadership coach. Dubbed The Checklist Guru™, she authors The Weekly Leadership Checklist™ and designed The Three Fundamentals of Leadership™ proprietary coaching curriculum.Melissa's 32-year career spans corporate industry, technology, small business start-ups, nonprofits, and higher education administration. She has held senior positions at start-up software companies and global technology organizations, and later led in such roles as chief of staff and vice president for communications, marketing, and enrollment, serving liberal arts colleges and a large public university. She also has founded two small businesses and co-founded two nonprofits, a children's museum and a genetics research foundation.Melissa earned a Master of Public Administration at Virginia Tech and a Bachelor of Arts at the University of Virginia. She also achieved the Accreditation in Public Relations credential and the Association of Governing Boards Board Professional Certificate. Having led award-winning creative teams, she was nominated for the American Marketing Association Nonprofit Marketer of the Year 2022 and named one of 30 Vice Presidents to Follow in 2018 by Leadership in the Digital Age.A natural public speaker and experienced writer, Melissa has spoken at dozens of national conferences and authored more than 100 papers and articles. Her first book, “The 30-60-90 Day Handbook: Checklists for Communications and Marketing Leaders in Higher Education,” is now available from the Council of Advancement and Support of Education. She has collaborated to organize four major TEDx events — including pitching the event and mentoring dozens of speakers —and led numerous conference planning committees. Throughout her three decades of leading internal teams, she developed many small and large professional development events, including a 10-course brand ambassador certificate program. She has contributed her leadership of communications strategy to significant fundraising campaigns, the largest of which was $400 million.Melissa serves as chair of the Public Relations Society of America Northeast District and immediate past president of the Central New York Chapter. She is a part-time adjunct instructor at Aurora University and previously taught at Utica University and the S.I. Newhouse School of Public Communications at Syracuse University.iMarketingMix LLC is a CASE Educational Partner, a Rising Team Channel Partner, and a CenterState CEO Member. As an entrepreneur, Melissa is a member of The Upside and the Central New York Women's Network. As an adjunct teacher, Melissa is a member of UPCEA, the online and professional education association.Author of The 30-60-90-Day Handbook: Checklists for Communications and Marketing Leaders in Higher Education (Council for Advancement and Support of Higher Education, 2025). - - - -Connect With Our Host:Jaime Hunthttps://www.linkedin.com/in/jaimehunt/https://twitter.com/JaimeHuntIMCAbout The Enrollify Podcast Network:Confessions of a Higher Ed CMO is a part of the Enrollify Podcast Network. If you like this podcast, chances are you'll like other Enrollify shows too! Enrollify is made possible by Element451 — the next-generation AI student engagement platform helping institutions create meaningful and personalized interactions with students. Learn more at element451.com.Attend the 2025 Engage Summit! The Engage Summit is the premier conference for forward-thinking leaders and practitioners dedicated to exploring the transformative power of AI in education. Explore the strategies and tools to step into the next generation of student engagement, supercharged by AI. You'll leave ready to deliver the most personalized digital engagement experience every step of the way.Register now to secure your spot in Charlotte, NC, on June 24-25, 2025! Early bird registration ends February 1st -- https://engage.element451.com/register

In this episode, host Heather Shea is joined by Dr. Brendan Cantwell and Dr. Demetri Morgan to break down a wave of federal actions reshaping higher education. From the NIH's ultimatum on DEI to a new executive order on accreditation—and threats to university tax-exempt status—they explore what these moves mean for institutional governance, research integrity, and academic freedom.

Join us for a PRessing On in Public Relations conversation on Acing the APR! Thinking about pursuing your APR but feeling overwhelmed? Not sure where to start—or how to stay on track? If you're nodding yes, this episode is made for you. Rachel and Liselle have been through the APR process themselves, and they're sharing the tips they wish they had when they started. From building your Readiness Review panel to tackling the exam with confidence, the PRessing On hosts break down what it really takes to earn your Accreditation in Public Relations. Whether you're just starting to explore the credential or you're knee-deep in study guides, you'll get honest insights, time-saving strategies, and encouragement to keep going. Ready to boost your career and join the ranks of accredited PR pros? Grab your study plan and press play. To learn more about earning your APR: www.praccreditation.org/apply/apr/ https://www.capio.org/apr _______________________________________________________ To connect with Liselle and Rachel, track them down at: Instagram: @RMG.Communications and @DeGravePR LinkedIn: www.linkedin.com/in/liselle-degrave/ https://www.linkedin.com/in/rachdickman/ ------------------------------------------------------------------ For more information visit ⁠⁠⁠PressingOnPodcast.com⁠ RMGComm.com DeGravePR.com

Made possible by The Lou Review Foundation Inc., a nonprofit dedicated to supporting local businesses and nonprofits by amplifying their mission through storytelling.In this inspiring episode of The Lou Review Podcast, host Rosa Hart sits down with Denise Sears, President and CEO of SOS (Supplies Over Seas) — a Louisville-based nonprofit transforming surplus medical supplies into life-saving resources around the world and in our own backyard.Denise shares her fascinating journey from international economics to nonprofit leadership, and how she helped evolve SOS from its original mission of international aid to a dual focus that now includes addressing local health inequities in Louisville.Throughout their conversation, Denise and Rosa explore:The power of partnerships and how accreditation has helped build trust with hospitals and global organizations.The critical importance of ethical practices in the medical supply chain.How volunteers are the heartbeat of SOS's mission, creating meaningful connections both locally and globally.SOS's approach to disaster relief, from hurricane zones to conflict areas, and how community-specific solutions save lives.Real-life stories of hope and transformation that remind us why this work matters.This episode is a powerful reminder of the interconnectedness of health and community well-being, and ends with a call to action: support your local initiatives and consider how your time, talents, or donations can make a global impact.

DEAR PAO: Required accreditation for national athletes prior to discount | April 22, 2025Visit our website at https://www.manilatimes.netFollow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotionSubscribe to our Digital Edition - https://tmt.ph/digitalSign up to our newsletters: https://tmt.ph/newslettersCheck out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimesVisit our website at https://www.manilatimes.netFollow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotionSubscribe to our Digital Edition - https://tmt.ph/digitalSign up to our newsletters: https://tmt.ph/newslettersCheck out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes Hosted on Acast. See acast.com/privacy for more information.

Episode 359: Lung Cancer Screening, Early Detection, and Disparities “I was actually speaking to a primary care audience back a few weeks ago, and we were talking about lung cancer screening. And they said, ‘Our patients, they don't want to do it.' And I said, ‘Do you remind them that lung cancer is curable?' Because everybody thinks it is a death sentence. But when you're talking about screening a patient, I think it's really important to say, ‘Listen, if we find this early, stage I or stage II, our chances of curing this and it never coming back again is upwards of 60% to 70%,'” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer screening. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by April 18, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer screening. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 313: Cancer Symptom Management Basics: Other Pulmonary Complications Episode 295: Cancer Symptom Management Basics: Pulmonary Embolism, Pneumonitis, and Pleural Effusion Episode 247: Tobacco Treatment for Patients With Cancer ONS Voice articles: Lung Cancer Screening and Early Detection Drastically Improves Survival Rates Pack-Year History Is a Biased and Inadequate Criterion for Lung Cancer Screening Eligibility, Researchers Say CMS Expands Eligibility Criteria for Lung Cancer Screening With Low-Dose Computed Tomography Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Clinical Journal of Oncology Nursing articles: Nurse-Led Tobacco Cessation for Veterans Using Motivational Interviewing in a Lung Cancer Screening Program Identifying Primary Care Patients at High Risk for Lung Cancer: A Quality Improvement Study Oncology Nursing Forum article: Patient–Provider Discussion About Lung Cancer Screening Is Related to Smoking Quit Attempts in Smokers ONS Tobacco, E-Cigarettes, and Vaping Learning Library American Cancer Society Lung Cancer Screening Guidelines American Lung Association lung cancer resources To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Unfortunately, the current state of lung cancer screening is pretty low. Our rate of uptake in eligible patients is somewhere between 6% and 20%. And that falls much further below what we see for screening, such as breast cancer screening, prostate cancer screening, and colorectal cancer screening. So certainly, we can do better.” TS 1:32 “If you quit more than 15 or 20 years, your risk of developing lung cancer at that point is significantly lower. And so that's why once patients have quit more than 15 years, they're actually not eligible for screening anymore—because their risk of developing lung cancer is dramatically reduced. And that takes into account when you are a primary care provider, pulmonary, whatever field you work in, and you are running a screening clinic each year that you screen the patient, you have to remind yourself when they quit smoking, because once they reach that 15 years, then they're no longer eligible for screening.” TS 5:17 “One of the strategies that they've used to get the word out is, I watch a lot of baseball. I love the Philadelphia Phillies, watch Phillies games. And so at least once a year, maybe even twice a year, they will take an inning of the baseball broadcast on TV and on the radio separately, and they will bring on either an oncologist or pulmonologist from one of the local cancer centers in our area, and the whole inning—between batters of course—they will talk about lung cancer screening and why it's beneficial.” TS 13:16 “Medicare always has its idiosyncrasies. So Medicare—I went over the rules with you, so the age, the smoking. They follow all of it, except they have a slight difference in age. They cover it for age 50 to 77, as opposed to 80.” TS 16:52 “I think just the other thing that people don't think about is that to go get a medical test done, no matter what test it is, typically people have to take time off of work. And it can be really hard to do that when you are relying on your job, maybe you don't have vacation time, maybe you have children at home that you need to get home to. When people are weighing the risk/benefit and thinking, ‘Well, I'd love to get screened for lung cancer, but I just can't find time to fit it into my schedule, and my job won't let me take off.' These are all things that we don't always think about if you have the luxury of just taking the day off.” TS 20:01

First call: https://fdrpodcasts.com/5522/my-girlfriend-summons-me-to-sin-freedomain-call-inIn this episode, I converse with a caller who shares his journey of self-discovery following a breakup. He discusses moving back in with family while pursuing an accreditation and the emotional complexities of caring for his brother with spinal muscular atrophy (SMA). We explore the impact of his past, including a confrontation with his parents about their parenting, and how these dynamics affect his relationships and future aspirations. I emphasize the importance of his independence while navigating familial obligations, ultimately guiding him to find a balance between supporting his brother and pursuing his own fulfillment. The discussion showcases the resilience needed to manage personal growth amidst emotional challenges.GET MY NEW BOOK 'PEACEFUL PARENTING', THE INTERACTIVE PEACEFUL PARENTING AI, AND THE FULL AUDIOBOOK!https://peacefulparenting.com/Join the PREMIUM philosophy community on the web for free!Subscribers get 12 HOURS on the "Truth About the French Revolution," multiple interactive multi-lingual philosophy AIs trained on thousands of hours of my material - as well as AIs for Real-Time Relationships, Bitcoin, Peaceful Parenting, and Call-In Shows!You also receive private livestreams, HUNDREDS of exclusive premium shows, early release podcasts, the 22 Part History of Philosophers series and much more!See you soon!https://freedomain.locals.com/support/promo/UPB2025

Andrea is tackling the real talk around launching a business without sacrificing your financial security. From building your safety net to shifting your money mindset, this conversation will empower you to move from hesitation to confident action.. . .0:00 - Intro2:09  - Deep Dive Into Launching a Business4:37 -  How Do You Build Something New Without Burning it All Down?7:02 - Financial Health isn't Separate From Your Purpose8:19 - Mindset and The Way You Think About Money9:14 - A Few Smart Strategies14:01 - You Need to Know Your Own Numbers16:14 -   Find Your Financial Support Circle18:16 - Ask Better Questions19:57 - Allowed to Move Boldly and Wisely . . . RESOURCES Download The Mindset Makeover⁠Get info about our upcoming Mastermind cohort!⁠⁠Wells Fargo Report: The Impact of Women-Owned Businesses⁠. . .CONNECT WITH KANDULAteam@kandulacommunications.com. . .CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

The Light Gate welcomes guest: Nichole ‘Coley' Weber, UFO experiencer, medium, channeler, podcaster. Date: April 14, 2025 Episode: 103 Discussion: UFOs, extraterrestrials, ghosts, mediumship, paranormal phenomena, dreams, auras… The Light Gate is delighted to welcome back Nichole Weber (Aka Coley.) Coley graduated from the University of Dubuque, earning a bachelor's degree in Aviation Management and Business minor. In addition, she graduated from Walden University with a Master's in Mental Health Counseling, and a 3.99 GPA, which holds Accreditation of Counseling and Related Educational Programs (CACREP). Member of Chi Sigma Iota, Omega Zeta Chapter, internationally recognized for high honors, integrity, and academic success. Coley considers herself an ordinary midwestern girl with extraordinary experiences. Around age 4 she realized she could see things others could not see. What started off as auras around people evolved into sight into another world of the dead. As the spiritual world manifested with time, Coley discovered she was able to communicate with the spirit realm, a gift that set her apart as a medium/channeler. These abilities were both a blessing and a challenge, offering profound insights while sometimes isolating from peers and family who couldn't understand her unique perspective. Coley experiences death dreams and in contrast could detect the miracle of life. In July 2017, Coley's journey took an even more remarkable turn when she became a UFO experiencer. That year, she encountered phenomena that many deem impossible, yet for her, it was another chapter in her ordinary extraordinary life. These experiences deepened her understanding of the universe and one's place within it, forever altering how she perceived reality. Coley has experienced both crafts and ET, markings, and a new path in life. Coley has been doing UFO, Paranormal, and the unknown radio. She currently hosts (along with her co-host Rodney Lundrigan) a podcast, SUBN8IONX SNX RADIO which you can find on youtube, and rock radio live. She and Rodney have an important and quickly growing group on facebook called, ET/UFO & OFF -WORLD ENTITIES SUPPORT GROUP. SUBN8IONX SNX RADIO is paving the way to the Experiencer's Disclosure. SNX Radio is having conversations with the top experts, unveiling mysteries about UFO, aliens. Sasquatch, Cryptids, Paranormal, off-world incidents, and more! Exploring Off-World Encounters: ET abductions, ET, UFO. Beyond the Stars: Exploring the Unraveling the Mysteries Cosmic Connections: Investigating the points of intersection of UFOs and Paranormal Activities, Sasquatch, and Off-World Entities. LINKS: https://rockradio.live/ https://snxradio.com/ https://www.facebook.com/groups/480435858665470 https://www.facebook.com/coleyufo https://www.facebook.com/ColeySNX https://www.youtube.com/@SNXRadio https://rockradio.live/coley-and-marquise-talk-show/ https://www.facebook.com/groups/815217970245823

Episode 77: Pediatric Obesity: The Role of GLP – 1 Receptors Evaluation and Credit:  https://www.surveymonkey.com/r/medchat77 Target Audience            This activity is targeted toward primary care physicians and advanced providers. Statement of Need This podcast will address the role of GLP – receptors in the treatment of pediatric obesity. As the prevalence of pediatric obesity is on the rise, the need for effective, evidence-based treatments is essential. This increase in pediatric obesity is associated with numerous health complications for the pediatric patient including type 2 diabetes, hypertension and cardiovascular diseases. Early intervention in the pediatric patient and management can prevent the progression of obesity with the goal of improving the long-term health of these individuals. Objectives  Define pediatric obesity. Discuss the key aspects of GLP – 1 receptors and their use of treatment of the pediatric patient. Explain the mechanisms and criteria for patient selection for GLP – 1 as a treatment option for obesity. Describe best practices integrating GLP-1 receptor agnostic into a broader treatment plan and appropriate monitoring and follow-up.   ModeratorMark McDonald, M.D., MHA, CPE System Vice President Pediatric Medical Affairs Medical Director, Norton Children's Louisville, Kentucky  Professor Department of Pediatrics Division of Critical Care UofL School of Medicine Louisville, Kentucky SpeakerSara Watson, M.D. Pediatric Endocrinologist Medical Director of the Type 2 Diabetes Program and the Health Weight Program Norton Children's Endocrinology Louisville, Kentucky Moderator and Planner Disclosures  The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose.   Speaker DisclosureThe speaker, Sara Watson, M.D. discloses a relevant financial relationship with the ineligible company Lilly as a principal investigator. All relevant financial relationships have been mitigated. Commercial Support  There was no commercial support for this activity.    Physician Credits Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing CreditsNorton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours.  In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.  For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org.   Resources for Additional Study/References  Characterizing GLP-1 Receptor Agonist Use in Preadolescent and Adolescent Populations https://pubmed.ncbi.nlm.nih.gov/39412809/ Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection https://pubmed.ncbi.nlm.nih.gov/33085056/   Date of Original Release | April 2025; Information is current as of the time of recording. Course Termination Date | April 2028 Contact Information | Center for Continuing Medical Education (502) 446-5955 or cme@nortonhealthcare.org   Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.  

“It's been known for quite a while that [KRAS] is a mutation that leads to cancer development, but for really over four decades, researchers couldn't figure out a way to target it. And so, it was often considered something that was undruggable. But all of this changed recently. So about four years ago, in 2021, we had the approval of the first KRAS inhibitor. So it's specifically a KRAS G12C inhibitor known as sotorasib,” Danielle Roman, PharmD, BCOP, manager of clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the KRAS inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by April 11, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to KRAS inhibitors used for cancer treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Cancer Symptom Management Basics series Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs ONS Voice articles: First KRAS-Targeted Therapy Receives FDA Approval for Lung Cancer Oncology Drug Reference Sheet: Adagrasib Oncology Drug Reference Sheet: Sotorasib ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Safe Handling of Hazardous Drugs (fourth edition) ONS course: Safe Handling Basics ONS video: What is the role of the KRAS biomarker in NSCLC? ONS Targeted Therapy Huddle Card ONS Oral Anticancer Medication Learning Library ONS Oral Anticancer Medication Toolkit ONS and NCODA Oral Anticancer Medication Compass Oral Chemotherapy Education Sheets Lumakras® (sotorasib) manufacturer website Krazati® (adagrasib) manufacturer website UpToDate Lexidrug (formerly Lexicomp) To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “If we look at specifically non-small cell lung cancer, this KRAS mutation is one of the most frequently detected cancer drivers or driver mutations. It's thought that about a quarter of cases of non-small cell lung cancer have this KRAS mutation, and it's usually a specific amino acid substitution that we see in non-small cell lung cancer, so what's known as KRAS G12C mutation.” TS 2:31 “Both of these agents, sotorasib and adagrasib, have the same mechanism of action. They bind to a pocket, very specifically on the KRAS G12C protein, and they lock it in an inactive state so that it can't cause that downstream uncontrolled signaling to happen. So they're kind of shutting down the signaling, and therefore you don't get that uncontrolled cell growth and proliferation.” TS 4:27 “Another big difference to point out, and one that is often used in clinical practice to differentiate when to use these agents, is specifically adagrasib is known to have activity in patients with metastatic non-small cell lung cancer that have active brain metastases. In the clinical trial, they included patients with active brain metastases, and they found that this drug has great [central nervous system] penetration. And so it may be considered the agent of choice in patients with brain metastases.” TS 7:19 “Other considerations—I think one of the big ones—is that there are a lot of drug interactions. Just specifically calling one out that I think is pretty impactful, is sotorasib has an interaction with acid-suppressing medications. So there is the recommendation to avoid [proton pump inhibitors] and H2 antagonists in patients receiving sotorasib. They can take antacids, but you would need to space those out from their dose of sotorasib.” TS 14:14 “This needs to be a collaborative endeavor to make sure these patients are monitored appropriately. We are putting a lot of responsibility on the patients with all of this. So, again, completely administered generally in the home setting, a lot of monitoring, a lot of adverse effects, need for reporting and management—so there's a lot happening here. And it takes a team to accomplish this and to do it right. And I firmly believe that this is often a collaborative effort between our pharmacy and oncology nursing teams to make this happen. Working together to ensure outreach to patients—I think that patients are often more successful with these medications with early identification of toxicities when we're doing scheduled outreach.” TS 19:44

We begin season 8 of Zoo Logic with a frank conversation with Dr. Jason Bruck and Billy Hurley about the proper role of accreditation organizations, as well as, their limitations.  When an accredited institution stumbles or allegations of poor animal well-being are made, what is the responsibility of accrediting bodies to investigate, act, and inform its members and the public as to its findings and remedies? Where is the dividing line between a professional trade organization's responsibilities to ensure adherence to its standards and guidelines and the government's legal authority to act to address animal well-being concerns?  In an age when news, information, and especially, opinions are instantly expressed on social and traditional media, how should professionals or members of the public effectively respond to animal welfare concerns so as to not make matters worse for the animals or the front line staff doing their best to care for them? Animal Care Software

In this episode, John Collins builds on the themes and recommendations covered in episode 87, with regards to forensic laboratory accreditation and its strengths and limitations. Seven policy priorities are discussed to help forensic science laboratories, their parent agencies, and their jurisdictions prevent instances of catastrophic misconduct before they happen. Season:  5 Episode:  88 Duration: 1:00:18 YOUTUBE CHANNELS Main Podcast Channel Highlights Channel FROM OUR SPONSOR Learn About the Innovators at Promega International Symposium on Human Identification REFERENCED RESOURCES Article: A Reality Check on Crime Lab Backlogs ABOUT YOUR HOST John Morrey Collins is a leadership and expertise coach specializing in working with clients in authoritative, high-stakes occupations, but with a primary emphasis on serving leaders, professionals, and organizations that support our complicated systems of criminal and civil justice. John started his private practice, Critical Victories, in 2013 after retiring his award-winning, 20-year career as a forensic laboratory scientist and executive administrator, having served as the Director of Forensic Science for the State of Michigan. His forensic technical expertise was in the examination and testing of firearms and firearm-related evidence, having provided expert courtroom testimony in approximately 130 criminal trials, including death penalty cases and Daubert hearings. John is also the author of three books on forensic science and criminal justice reform. In 2022, he released his fourth book, “The New Superior – A Better Way to Be the One in Charge,” which is available in print and audio. John's many career highlights include his part in the forensic investigation of the Atlanta serial bombings, which included the bombing of the 1996 Olympics in Atlanta, as well as his 2013 participation in a historic meeting with the US Attorney General and other firearm experts to discuss the Sandy Hook Elementary School shooting. John has a master's degree in organizational management and is formally certified as a Senior HR Professional by the Society for Human Resource Management (SHRM). In 2012, John was trained as a professional coach by the College of Executive Coaching, and he became certified as a Gallup Strengths Coach in 2022. He lives and works near Detroit, Michigan. For more books and other information, please visit www.criticalvictories.com.

In this episode of The InspirED Podcast, Andrea exposes the systemic barriers that keep women financially vulnerable and deliver actionable strategies to build economic resilience, advocate for change, and create pathways to true financial independence.. . . EPISODE CHAPTERS0:00 - Intro1:02 -  Financial Vulnerability2:30 -   Understand the System4:13 - Wealth Represents Security5:08 -  The Motherhood Penalty6:50 - Consequences of Economic Inequality10:01 - The Body Keeps the Score11:42 - The Glass Ceiling13:58 - Structural Barriers16:35 -  Getting Comfortable with Concepts18:56 - Salary Negotiation20:49 - Power of Connection22:22 - Financial Freedom is not Selfish . . . RESOURCES ⁠⁠⁠⁠⁠Get info about our upcoming Mastermind cohort!. . .CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Explore how to shield your big dreams from the energy vampires and doubt dealers who threaten your vision. In this episode of The InspirED Pod, we reveal the hidden costs of negativity on ambitious women and deliver a power-packed strategy to protect your confidence, set boundaries without guilt, and transform criticism into fuel for your success.. . . EPISODE CHAPTERS0:00 - Intro1:05 -  Plant a Little Seed of Self-Doubt3:55 -   Compromising Your Resources5:55 - Emotional Labor8:46 -  The People You Keep the Closest12:43 -  Shielding Your Energy 14:09 - Develop Positive Influences in Your Life15:36 - The Most Powerful Shift16:33 - The Negative Voice18:05 -  Your Vision Exists for a Reason . . . RESOURCES ⁠⁠⁠Mindset Makeover. . .CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

In this episode, the Payments Professor, Kevin Olsen, speaks with Ashley Mustico from Nacha about the AAP (Accredited ACH Professional) accreditation. They discuss the importance of the AAP in the electronic payments industry, the journey into electronic payments, the benefits of obtaining the AAP for both individuals and organizations, the format and preparation for the AAP exam, and what to do after passing the exam, including maintaining the accreditation. The conversation emphasizes the value of education and professional development in the payments industry. Takeaways: Nacha governs the ACH network and offers accreditations. The AAP accreditation signifies expertise in the ACH network. Individuals should pursue AAP after gaining at least two years of payment experience. Getting an AAP can enhance career prospects and salary. Organizations benefit from having AAPs on staff for compliance and risk management. The AAP exam consists of 120 multiple-choice questions, with 100 scored. Candidates can find out if they passed the exam on the same day. Preparation through Payments Associations significantly increases the chances of passing. Continuing education is required to maintain AAP accreditation every five years. Celebrating the achievement of AAP is essential for personal and professional growth. Learn more from the Payments Professor "We make learning about payments rules and regulations fun and easy!" www.PaymentsProfessor.com

“I genuinely think nurses and pharmacists need to know why these medicines are called hedgehog inhibitors so that we can, in fact, effectively educate our patients. Just because to date, this class has the weirdest name I've encountered, and I almost expect at this point that my patients are going to ask me about it. I think that we need to be informed that, just on, where do these names come from, why is it called this, and does it matter to my patient?” Andrew Ruplin, PharmD, clinical oncology pharmacist at Fred Hutchinson Cancer Center in Seattle, WA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about hedgehog pathway inhibitors.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by March 14, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learners will report an increase in knowledge related to hedgehog pathway inhibitors used for cancer treatment.  Episode Notes   Complete this evaluation for free NCPD.  ONS Podcast™ Pharmacology 101 series  ONS Voice articles: An Oncology Nurse's Guide to Targeted Therapy FDA Approves Glasdegib for AML in Adults Aged 75 or Older or Who Have Comorbidities Oncology Drug Reference Sheet: Glasdegib Understanding Precision Medicine Therapeutics ONS courses: Genomic Foundations for Precision Oncology ONS Cancer Biology™   ONS Guidelines™ and Symptom Interventions:  Diarrhea Fatigue ONS Huddle Card: Targeted Therapy ONS Learning Libraries: Oral Anticancer Medication Pain Management  Oral Chemotherapy Education Sheets American Association for Cancer Research article: Hedgehog Pathway Inhibitors: A New Therapeutic Class for the Treatment of Acute Myeloid Leukemia American Journal of Clinical Dermatology article: Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies Cureas article: Hedgehog Pathway Inhibitors: Clinical Implications and Resistance in the Treatment of Basal Cell Carcinoma International Journal of Molecular Sciences article: Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance  To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode  “Many patients unfortunately will have side effects with this class. I mean—and I know that's not controversial—but you actually find callouts in some of the kind of the national consensus guidelines. These treatments might not be tolerable for a decent number of patients. Some of these side effects can certainly reduce quality of life. Again, nothing that controversial here when we say it out loud, but just the frequency with which it occurs can make it quite difficult for some patients.” TS 9:13  “Certainly, based on what we said before, I think one of the easiest things to do for patients starting this class is to just make sure that they have really classical supportive medicines like antidiarrheals and antiemetics before they start treatment. Diarrhea, nausea occurred in about 20%–40% of patients across trials. So certainly patients should be aware of that risk. Again, not a controversial side effect, but it's just simple things we can do to make sure that our patients are quick to start treatment is to make sure that they have these medicines and they're educated on how to use them.” TS 11:21  “I think patients need to be aware that side effects, as I had mentioned before, can be especially frequent with this class. So for a patient, they need to be aware that communicating your needs to your oncology team is really crucial to their own ability to use these treatments with minimal interruptions.” TS 14:45  “I think that regardless of whoever is following up with our patients, though, as our arsenal of oral anticancer therapies does continue to expand, both nurses and pharmacists need to have specialized knowledge of these agents to be successful in their patient care roles.” TS 18:28  “When there are clear recommendations for reproductive health, as I summarized before with these agents, I obviously think we need to be aware of them and not just defer to these generic recommendations. Because if you just defer to, ‘Well, use barrier contraception and then for a week after your last dose,' you know, ‘Okay, it's not true with these agents.'” TS 24:37   

The Future of Education Now 2025 (#FOEN25) festival, held at WAB from March 13 to 15, brought together students, educators, parents, and thought leaders to explore the evolving landscape of education (add link). In this special episode of the WAB Podcast, we have a recording from a very special panel from FOEN25. Moderated by Stephen Taylor, WAB's Director of Innovation in Learning and Teaching, this conversation was joined by three WAB students: Ryan from Grade 10 and Cali and Hannah from Grade 11, and global education leaders including:    Jason Cummings, Director of Member Engagement of Mastery Transcript Consortium (MTC)  Ellen Heyting, Project Lead for International Networks and Credentialing from Melbourne Metrics  Trillium Hibben, Director of Commission on International Education at New England Association of Schools and Colleges (NEASC)  Jane Larsson, Executive Director of the Council of International Schools (CIS)  Angela Meikle, Global Head of Private IB Schools of International Baccalaureate (IB)  Together, the panel explored how education is evolving beyond traditional assessments, emphasizing competency-based learning and the recognition of student-driven achievements. Speakers highlighted how new tools and approaches are providing a more holistic view of student progress, moving beyond grades to assess real-world skills and competencies. Schools and universities are shifting towards formative, competency-based assessments that allow students to showcase not just what they know, but what they can do.  Students shared how their projects—ranging from scientific research to organizing student-led initiatives—illustrate the impact of hands-on, real-world learning. Their experiences underscored how students thrive when given opportunities to apply their knowledge beyond the classroom. The discussion also emphasized the need for new ways to credential essential skills such as collaboration, ethical decision-making, and leadership.  Another key theme was the increasing role of student voices in shaping education. Schools and organizations are moving towards more collaborative models, ensuring that students are active participants in designing their learning experiences. Accreditation processes are also evolving, focusing more on the impact of education rather than compliance, to better support students in a rapidly changing world.  As the session concluded, the panelists expressed optimism about the future of education, emphasizing the importance of collaboration between schools, universities, and accreditation bodies to create learning environments that develop both knowledge and essential competencies. To hear the full discussion, tune in to this extra special episode of the WAB Podcast. 

If we don't intentionally find joy in our everyday lives, we risk burning out before we ever reach our goals. Join Andrea, as she dives into how to shift our perspective, reclaim our joy, and romanticize our lives not as a luxury, but as a necessity.. . . EPISODE CHAPTERS0:00 - Intro0:40 -  A Concept that's Empowering1:52 -   Am I Actually Enjoying My Life?2:26 - The Uncomfortable Truth4:44 -  Mental Shift6:07 -  Why Does Romanticizing our Lives Matter?8:04 - The Roses are out There10:22 - Choose to Celebrate Pleasure14:11 - Step Confidently into Life . . . RESOURCES ⁠⁠The Vision Board Playbook: Design Your Dream Year⁠⁠. . .CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Send us a textIn this episode of the Hotflash inc Podcast, host Ann Marie McQueen sits down with fellow journalist and midlife advocate, Tamsen Fadal. A veteran Emmy Award-winning news anchor, Tamsen has transformed her career into a powerful force for women in midlife. From creating the groundbreaking PBS documentary The M Factor: Shredding the Silence on Menopause to her upcoming book How To Menopause (out March 2025), Tamsen is on a mission to change the conversation around menopause, confidence and aging.Connect with Tamsen Fadal:Website: www.tamsenfadal.comIG: @tamsenfadalTikTok: @tamsenfadalYouTube: Tamsen FadalThe M Factor Documentary: Watch hereThanks to our sponsor Timeline Nutrition Mitopure supports cellular energy and longevity—now available with a 10% discount! Visit timeline.com/HOTFLASH and use the code HOTFLASH to claim your offer!From The M Factor team: This partial statement is in response to Hotflash inc's request for comment in light of recent reports and fact-checking of the film by ob-gyn Dr Jen Gunter and published on her platform, The Vagenda. The M Factor: Shredding the Silence on Menopause” documentary earned continuing medical education (CME) Accreditation. On October 17, 2024 the Federation of State Medical Boards (FSMB) hosted a 90-minute live webinar offering continuing medical education (CME) credit for healthcare providers. The event featured the documentary “The (M) Factor: Shredding the Silence on Menopause,” which was followed by a moderated discussion with menopause experts Dr. Stephanie Faubion, Mayo Clinic and The Menopause Society and Dr. Wen Shen, Johns Hopkins Medical,  moderated by FSMB board members and one of the film producers. Due to the limited capacity FSMB had for live registrations, CME credit was extended to those on the waitlist who accessed the recorded webinar online. After the live event, FSMB provided access to the recorded webinar for a limited period, and that window closed as scheduled. Accreditation remains intact for all participants, whether live or virtual. The FSMB CME webinar and accreditation concluded on November 21, 2024. We stand by our film and the medical doctors who shared their expertise with us. We recognize that others have different viewpoints.  We respect them all and we look forward to working together to help women live longer healthier lives.  Join the Hotflash inc perimenoposse: Web: hotflashinc.comNewsletter: Hotflash inc. on SubstackTikTok: @hotflashincInstagram: @hotflashincX: @hotflashinc Episode website: Hotflashinc Listen on: Apple Podcasts | Spotify | Google Podcasts | YouTube | Substack See hotflashinc.com/privacy-policy for privacy information

“You can give someone a survivorship care plan, but just giving them doesn't mean that it's going to happen. Maybe there's no information about family history. Or maybe there's information and there's quite a bit of family history, but there's nothing that says, ‘Oh, they were ever had genetic testing,' or ‘Oh, they were ever referred.' So the intent is so good because it's to really take that time out when they're through with active treatment and, you know, try to help give the patient some guidance as to what to expect down the line,” Suzanne Mahon, DNS, RN, AOCN®, AGN-BC, FAAN, professor emeritus at Saint Louis University in Missouri, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about breast cancer survivorship.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by March 14, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learners will report an increase in knowledge related to breast cancer survivorship.  Episode Notes   Complete this evaluation for free NCPD.   Previous ONS Podcast™ site-specific episodes: Episode 350: Breast Cancer Treatment Considerations for Nurses  Episode 348: Breast Cancer Diagnostic Considerations for Nurses  Episode 345: Breast Cancer Screening, Detection, and Disparities  ONS Voice articles: Breast Cancer Prevention, Screening, Diagnosis, Treatment, Side Effect, and Survivorship Considerations  Improve Management of Common Symptoms for Breast Cancer Survivors  Nursing Considerations for Breast Cancer Survivorship Care  Sexual Considerations for Patients With Cancer ONS books:  Breast Care Certification Review (second edition)  Guide to Breast Care for Oncology Nurses  ONS course: Breast Cancer Bundle  ONS Learning Libraries:  Breast Cancer  Genomics and Precision Oncology  Nurse Navigation  Oral Anticancer Medication   Survivorship  ONS Guidelines™ and Symptom Interventions:  Anxiety  Cognitive Impairment  Depression  Fatigue  Clinical Journal of Oncology Nursing article: Survivorship Care: More Than Checking a Box  Clinical Journal of Oncology Nursing supplement: Survivorship Care  American Cancer Society:  Cancer Treatment and Survivorship Facts and Figures  Survivorship: During and After Treatment  Livestrong® Program at the YMCA  National Comprehensive Cancer Network  National Cancer Institute Breast Cancer—Patient Version    To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode  “I think the biggest thing is to really communicate is that people are living with breast cancer for a long, long periods of time, and a lot of that with really good quality overall.” TS 4:07   “As a general rule, they're going to be seen by the breast surgeon probably every four to six months for a while. After about five years, a lot of times people are ready to say, ‘Okay, annually is okay.' And eventually they may let that drop off. But it also depends on did they have a mastectomy? Did they have breast conserving surgery? And then if they had reconstruction with an implant, how often do they see the plastic surgeon? Because they need to check integrity of the implant. So those schedules are really individualized.” TS 13:24  “When you think about long-term effects, I think you need to kind of think about that survivors can have both acute and long-term chronic effects. And a lot of that depends on the specifics of the treatment they had. I think as oncology nurses, we're used to, ‘We give you this chemotherapy or this agent, and these are the side effects.'” TS 15:36  “The diet issues are huge. And I think we are slow to refer to the dietician, you know, you can get them a couple of consults and because you're saying to them, ‘This is really important. We need you to lose weight or we need you to eat more of this.' Ideally, fruits and vegetables are going to be about half of your plate. And what's the difference between a whole grain and not, less processed foods, making sure that they're getting enough protein. And then once again, really kind of making sure that they're not taking a lot of supplements and extra stuff because we don't really understand all that fully and it could be harmful.” TS 34:53  “Breast cancer is a long, long journey, and I think you should never underestimate the real difference that nurses can make. I think they can ask those tough questions. And I think ask the questions that are important to patients that patients may be reluctant to ask. I think giving patients permission to talk about those less-talked-about symptoms and acknowledge that those symptoms are real and that there are some strategies to mitigate those symptoms.” TS 42:28   

Women bring a unique set of strengths to leadership—qualities that foster collaboration, innovation, and resilience in teams. This week, Andrea discusses how leading with empathy has redefined business success across industries.. . . .EPISODE CHAPTERS0:00 - Intro0:39 -  Reshaping the Business World1:27 -   Effective Leadership Has Evolved3:14 - Gender Diversity On Executive Teams4:14 -  Leaders Prioritize Empathy5:47 - The Multiplier Effect7:34 - How Can We Bring More Empathy?8:36 - Create a Culture of Trust and Authenticity. . . .RESOURCES Download the Hacktivity. . .CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Higher education accreditation influences everything from institutional reputation to student opportunities, yet there are concerns that it has become more about bureaucracy than educational quality. In this episode, Christopher Bjornstad, executive director of A3STEP, joins host, Jason Altmire, to share his vision for a new accreditor that prioritizes student outcomes over excessive institutional governance. He also discusses how accreditors could better serve career education and skilled trades programs, which are often overlooked by traditional models. To learn more about Career Education Colleges & Universities, visit our website.

When it comes to the online world, certification courses are booming!   With two certification course clients being guided through our Done For You services, I wanted to be sure you understand the value of this offer, why you want to add it as a major milestone, and when it's ideal for you to go for it.   That's why in this episode, you'll learn: ✔️ Why online certification courses are so attractive to potential students; ✔️ How to know when it's the right time to launch one for your brand and reputation; and ✔️ The powerful components that can be game-changers for your business.   Tune in, and let's get you moving!   Is a certification course your next program? Let us take care of the details with our high-end, fully customized done-for-you service. Find out more and book a call here. (http://coursecreationboutique.com/course)  

In the news today: For our first story of the day focusing on campus news, MSU's status reaffirmed after accreditation scare. For our second story focusing on more campus news, MSU unveils final design concepts for permanent campus shooting memorial. For our final story focusing on culture, MSU's African Studies Center celebrates its 65th anniversary.

Lots of big news this week. Funnel week in the state legislature, man with a loaded gun visits city council, and most importantly... our senator has sex??? Call us at (319) 849-8733! Go here for full episode notes: https://www.patreon.com/posts/123931054 https://rockhardcauc.us

In celebration of International Women's Day, Andrea explores the transformative power of women supporting women. Because when women empower each other to collaborate instead of compete, we all win.  Join us for this week's episode of the InspirED Podcast as Andrea discusses the incredible impact of lifting each other up.I want to hear from you! How have women supported you in your journey? What strategies have you used to collaborate rather than compete? Send your stories to team@kandulacommunications.com, and your story might be featured on an upcoming episode. . . .EPISODE CHAPTERS0:00 - Intro0:40 -  Happy International Women's Day1:30 -   Topic Close to My Heart3:29 - Support Each Other...Multiply Opportunities4:38 -  Build Something Authentic and Passionate5:37 - Actionable Strategies8:59 - What Can I Learn From Her Path?10:22 - Breakthrough Roadblocks. . .RESOURCES ⁠⁠⁠⁠Mindset Makeover Challenge. . .CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

“Now, what we found is that epigenetics is actually heritable and it's actually reversible. And we can now manipulate these principles with pharmacotherapy drugs,” Eric Zack, RN, OCN®, BMTCN®, clinical assistant professor at Loyola College Chicago Marcella Niehoff School of Nursing in Chicago, IL, and RN3 at Rush University Medical Center in Chicago, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the epigenetics drug class.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.75 contact hours (including 40 minutes of pharmacotherapeutic content) of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by February 28, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learners will report an increase in knowledge related to the epigenetics drug class.  Episode Notes   Complete this evaluation for free NCPD.  ONS Podcast™ Pharmacology 101 series ONS Voice articles: Financial Navigation During Hematologic Cancer Saves Patients and Caregivers $2,500 Oncology Drug Reference Sheets What Is MCED Testing? ONS book: Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (Fourth Edition) ONS Biomarker Database ONS course: Genomic Foundations for Precision Oncology ONS Huddle Card: Financial Toxicity  ONS Learning Libraries: Genomics and Precision Oncology Oral Anticancer Medication American Cancer Society: Patient Programs and Services Centers for Disease Control and Prevention: Epigenetics, Health, and Disease Leukemia & Lymphoma Society: Financial Support National Institutes of Health: Epigenetics University of Pennsylvania: Epigenetics Institute University of Utah: Genetic Science Learning Center To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode  “Epigenetics is influenced by several factors. Right now, there's about seven of them that we've identified, and we can only manipulate right now about two of those seven. So the first one is DNA methylation. When you methylate DNA, that's adding or subtracting a methyl group, which is CH3, chemically. The addition of methyl to DNA tightens the DNA around the chromatin, which then can block some genes from being expressed.” TS 7:21  “Histones basically package DNA into the chromatin, which is a mixture of DNA and proteins, and they spool around this structure like the DNA is coiled around that. And again, it has to do with how tight or loose that is coiled. That determines if the genes are expressed or not. And again, we found that histones also play a role in DNA repair as well as regulating the cell cycle.” TS 8:21  “When we're dealing with the azacitidine and decitabine, these drugs cause pancytopenia. Pancytopenia is neutropenia, thrombocytopenia, and anemia. So it affects the complete blood count. We see GI toxicity, nausea, vomiting, diarrhea, constipation, sometimes mouth sores, and urticaria—hives.” TS 15:34  “It's really, really important to take these drugs exactly as they are prescribed. They have to follow the doctor's orders carefully, which requires taking them properly, doing the proper follow up. There's a lot of blood tests and appointments that we have to do to make sure that everything is okay. And again, because we know when there is nonadherence, the disease progresses and becomes resistant, so that's a really, really important teaching point. We have to monitor the patient for expected side effects and unexpected side effects.” TS 23:58  “Now, we expect the landscape to change dramatically over the next few years. And again, it's just an explosion of science information. As we learn more about the science, it's going to translate into practice. We're always identifying new biomarkers. These biomarkers are essentially DNA mutations or variations. There's so many variants of unknown significance.” TS 30:02  “Every patient deserves biomarker testing. Very important, whether it's through IHC, polymerase chain reactions, or the most common next-gen sequencing. Again, there's several companies out there that have standard kits available.” TS 31:33  “This is a precision medicine. This is what we've always dreamed about—tailoring the treatment to the specific patient. We've gone away from treating standard diseases, like lung cancer and breast cancer, the way they're supposed to be treated to now looking at these biomarkers and using epigenetic drugs and other medications tailored to those variants that that patient is having, not necessarily based on their disease type.” TS 33:59   

This Week in Startups is brought to you by…Lemon.io. Get 15% off your first 4 weeks of developer time at https://Lemon.io/twistNorthwest Registered Agent. Get more privacy, more options, and more done—visit northwestregisteredagent.com/twist today!Vapi. Go to Vapi.ai and use code Twist200 to get $200 in creditsToday's show: Jason interviews Rahul Vohra, CEO and founder of Superhuman, and Vlad Tenev, CEO and co-founder of Robinhood. This is a packed episode featuring founder tips, fun stories about how Superhuman and Robinhood got their start and much more!Timestamps:(0:00) Episode teaser(2:13) Product market fit and founder journeys(3:25) Jason's investment in Superhuman and market positioning(5:14) AI's role and features in Superhuman(10:25) Lemon.io. Get 15% off your first 4 weeks of developer time at https://Lemon.io/twist(14:37) Targeting users and competitive advantages(22:23) Evolution and new features of Superhuman(20:52) Northwest Registered Agent. Get more privacy, more options, and more done—visit northwestregisteredagent.com/twist today!(24:37) Tackling spam with Superhuman's AI(27:05) Custom auto labels and email classification(29:47) Vapi. Go to Vapi.ai and use code Twist200 to get $200 in credits(32:03) Superhuman's auto reminders and drafts(34:14) Vlad Tenev and the origins of Robinhood(39:31) Product design philosophies of Robinhood and Superhuman(49:29) Scaling design principles and investment decisions(52:31) Subjectivity in product design(55:14) Customer feedback in product development(1:00:00) Superhuman's subscription model and customer acquisition(1:05:11) PR strategies and news hijacking(1:08:33) Robinhood's waitlist and viral moments(1:12:06) Investment experiences with Robinhood(1:13:35) Navigating company valuation fluctuations(1:15:03) Influences on Vlad Tenev and new Robinhood desktop product(1:20:11) Diversification of Robinhood's business(1:22:02) Company resilience and employee reorganization(1:25:52) Crypto regulation and startup mentality(1:30:05) Investment trends among Robinhood users(1:31:12) Retail benefits for startups and capital raising challenges(1:34:04) Accreditation for private investing and solutionsSubscribe to the TWiST500 newsletter: https://ticker.thisweekinstartups.comCheck out the TWIST500: https://www.twist500.comSubscribe to This Week in Startups on Apple: https://rb.gy/v19fcpLinks from this episode:Check out Superhuman: https://superhuman.com/Check out Robinhood Legends: https://robinhood.com/us/en/legend/Article “How Superhuman Built an Engine to Find Product Market Fit**”:** https://review.firstround.com/how-superhuman-built-an-engine-to-find-product-market-fit/Check out Rick Rubin's book: https://www.amazon.ca/Creative-Act-Way-Being/dp/0593652886Article on Bezos and Washington Post: https://www.newsweek.com/bezos-makes-big-change-washington-post-opinion-focus-endorsed-musk-2036618Media Bias Chart: https://www.allsides.com/media-bias/media-bias-chartCheck out “Working Backwards” book about Amazon insights: https://www.amazon.ca/Working-Backwards-Insights-Stories-Secrets/dp/1250267595Check out Rahul's article on acquisition: https://www.linkedin.com/pulse/rip-mailbox-founders-how-stop-worrying-love-being-acquired-vohra/Follow Rahul:X: https://x.com/rahulvohraLinkedIn: https://www.linkedin.com/in/rahulvohra/Follow Vlad:X: https://x.com/vladtenevLinkedIn: https://www.linkedin.com/in/vlad-tenev-7037591b/Follow Jason:X: https://twitter.com/JasonLinkedIn: https://www.linkedin.com/in/jasoncalacanisThank you to our partners:(10:25) Lemon.io. Get 15% off your first 4 weeks of developer time at https://Lemon.io/twist(20:52) Northwest Registered Agent. Get more privacy, more options, and more done—visit northwestregisteredagent.com/twist today!(29:47) Vapi. Go to Vapi.ai and use code Twist200 to get $200 in credits

Hey! We're taking a hiatus from the podcast while the team focuses on becoming an accredited organization for continuing education. We're developing new courses to bridge the gap between graduate education and real-world practice.In the meantime, we're inviting clinicians to contribute to paid blog posts and articles— we want to build a community dedicated to quality education and patient care.Stay informed of upcoming content by subscribing to our email list at www.realworldnp.com/guide.Apply to become a blog post writer here!For a full transcript and conversation chapters, visit the blog http://www.realworldnp.com/blog/podcast-break Hosted on Acast. See acast.com/privacy for more information.